This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Calliditas Therapeutics Suisse Sa. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Benjamin Perry
Introduction
Benjamin Perry is an accomplished inventor based in Collonges-sous-Salève, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that serve as NADPH oxidase inhibitors. His work is crucial for addressing various disorders related to Nicotinamide adenine dinucleotide phosphate oxidase.
Latest Patents
Perry holds a patent for his innovative compounds, which are disclosed as pharmaceutical compositions aimed at treating and/or preventing conditions associated with NADPH oxidase. This patent highlights his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Throughout his career, Benjamin Perry has been associated with Calliditas Therapeutics Suisse SA, where he has played a pivotal role in research and development. His expertise in pharmacology and innovative thinking has positioned him as a key figure in his field.
Collaborations
Perry has collaborated with notable colleagues, including Andrew Sharpe and Sylvain Celanire. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Benjamin Perry's contributions to the field of pharmaceutical innovation are noteworthy. His work on NADPH oxidase inhibitors exemplifies the impact of dedicated inventors in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile